COPD comorbidities network

Multimorbidity frequently affects the ageing population and their co-existence may not occur at random. Understanding their interactions and that with clinical variables could be important for disease screening and management. In a cohort of 1969 chronic obstructive pulmonary disease (COPD) patients and 316 non-COPD controls, we applied a network-based analysis to explore the associations between multiple comorbidities. Clinical characteristics (age, degree of obstruction, walking, dyspnoea, body mass index) and 79 comorbidities were identified and their interrelationships quantified. Using network visualisation software, we represented each clinical variable and comorbidity as a node with linkages representing statistically significant associations. The resulting COPD comorbidity network had 428, 357 or 265 linkages depending on the statistical threshold used (p≤0.01, p≤0.001 or p≤0.0001). There were more nodes and links in COPD compared with controls after adjusting for age, sex and number of subjects. In COPD, a subset of nodes had a larger number of linkages representing hubs. Four sub-networks or modules were identified using an inter-linkage affinity algorithm and their display provided meaningful interactions not discernible by univariate analysis. COPD patients are affected by larger number of multiple interlinked morbidities which clustering pattern may suggest common pathobiological processes or be utilised for screening and/or therapeutic interventions. COPD patients are affected by interlinked comorbidities forming structured networks http://ow.ly/MT4XT

[1]  Bruce Leff,et al.  The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008 , 2012, BMC Pulmonary Medicine.

[2]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[3]  L. Fabbri,et al.  Efficacy of standard rehabilitation in COPD outpatients with comorbidities , 2010, European Respiratory Journal.

[4]  T. Molen Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. , 2010 .

[5]  B. Celli,et al.  Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index. , 2014, Chronic obstructive pulmonary diseases.

[6]  K. Zou,et al.  Risk assessment of readmissions following an initial COPD-related hospitalization , 2013, International journal of chronic obstructive pulmonary disease.

[7]  S. Mody,et al.  Haemoglobin level and its clinical impact in a cohort of patients with COPD , 2007, European Respiratory Journal.

[8]  J. Prochaska Smoking and mental illness--breaking the link. , 2011, The New England journal of medicine.

[9]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[10]  P. Jones,et al.  Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification , 2012, European Respiratory Journal.

[11]  Martijn A Spruit,et al.  Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[12]  Jean-Loup Guillaume,et al.  Fast unfolding of communities in large networks , 2008, 0803.0476.

[13]  D. Coultas,et al.  Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. , 2000, Archives of internal medicine.

[14]  Mario Cazzola,et al.  Prevalence of Comorbidities in Patients with Chronic Obstructive Pulmonary Disease , 2010, Respiration.

[15]  D. Mannino,et al.  Ageing and the epidemiology of multimorbidity , 2014, European Respiratory Journal.

[16]  Craig E Wheelock,et al.  Network analysis in the investigation of chronic respiratory diseases. From basics to application. , 2014, American journal of respiratory and critical care medicine.

[17]  J. Soriano,et al.  Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. , 2010, American journal of respiratory and critical care medicine.

[18]  N. Christakis,et al.  The Spread of Obesity in a Large Social Network Over 32 Years , 2007, The New England journal of medicine.

[19]  B. Celli,et al.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[20]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[21]  A. Hansell,et al.  Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. , 2005, Chest.

[22]  L. Fabbri,et al.  Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation , 2008, Thorax.

[23]  J. Roca,et al.  Network medicine analysis of COPD multimorbidities , 2014, Respiratory Research.

[24]  T. van der Molen Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. , 2010, Primary care respiratory journal : journal of the General Practice Airways Group.

[25]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[26]  Alan D. Lopez,et al.  Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[27]  P. Villari,et al.  Comorbidity, Hospitalization, and Mortality in COPD: Results from a Longitudinal Study , 2010, Lung.

[28]  M. Puhan,et al.  Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. , 2014, Journal of clinical epidemiology.

[29]  J. Wedzicha,et al.  The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. , 2012, Chest.

[30]  Robert A Wise,et al.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee , 2007, Thorax.

[31]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[32]  M. Puhan,et al.  Impact of co-morbidities on self-rated health in self-reported COPD: An analysis of NHANES 2001–2008 , 2013, COPD.

[33]  D. Mannino,et al.  Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD , 2008, European Respiratory Journal.

[34]  S. Hall,et al.  Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. , 2009, Annual review of clinical psychology.

[35]  Ulrike Held,et al.  Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index , 2009, The Lancet.

[36]  Mathieu Bastian,et al.  Gephi: An Open Source Software for Exploring and Manipulating Networks , 2009, ICWSM.

[37]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[38]  Niels H Chavannes,et al.  Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. , 2009, American journal of respiratory and critical care medicine.

[39]  E. Wouters,et al.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[40]  F. Dekker,et al.  The influence of COPD on health-related quality of life independent of the influence of comorbidity. , 2003, Journal of clinical epidemiology.

[41]  Albert-László Barabási,et al.  A Dynamic Network Approach for the Study of Human Phenotypes , 2009, PLoS Comput. Biol..

[42]  M. Cosio,et al.  Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors. , 2011, American journal of respiratory and critical care medicine.

[43]  R. Rodríguez-Roisín,et al.  Disease progression in young patients with COPD: rethinking the Fletcher and Peto model , 2014, European Respiratory Journal.

[44]  D. O’Neill,et al.  Epidemiology of multimorbidity , 2012, The Lancet.

[45]  B. Celli,et al.  The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.

[46]  J. Bourbeau,et al.  Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. , 2008, American journal of respiratory and critical care medicine.

[47]  B. Celli,et al.  Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. , 2011, American journal of respiratory and critical care medicine.

[48]  S. Muro,et al.  Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation , 2008, Thorax.

[49]  Y. Ben-Shlomo,et al.  A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. , 2002, International journal of epidemiology.

[50]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[51]  M E J Newman,et al.  Modularity and community structure in networks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Novotná [Results of a longitudinal study]. , 1974, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete.

[53]  N. Christakis,et al.  SUPPLEMENTARY ONLINE MATERIAL FOR: The Collective Dynamics of Smoking in a Large Social Network , 2022 .

[54]  B. Carleton,et al.  Beta-blocker use and COPD mortality: a systematic review and meta-analysis , 2012, BMC Pulmonary Medicine.

[55]  Josep Roca,et al.  Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes , 2010, Thorax.

[56]  D. Caillaud,et al.  Clinical COPD phenotypes: a novel approach using principal component and cluster analyses , 2010, European Respiratory Journal.

[57]  M. Etminan,et al.  Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. , 2006, Journal of the American College of Cardiology.

[58]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[59]  Albert-László Barabási,et al.  A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease , 2014, BMC Systems Biology.

[60]  F. Schellevis,et al.  Multimorbidity and comorbidity in the Dutch population – data from general practices , 2012, BMC Public Health.

[61]  Christopher M. Danforth,et al.  Twitter reciprocal reply networks exhibit assortativity with respect to happiness , 2011, J. Comput. Sci..

[62]  A. Barabasi,et al.  Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.

[63]  P. Bindels,et al.  Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. , 2001, Journal of clinical epidemiology.

[64]  H. Satoh,et al.  Lung cancer patients with chronic obstructive pulmonary disease. , 2001, Oncology reports.